| Matthew Scott Robinson, MD | |
|
1722 High St, Hopkinsville, KY 42240-1936 | |
| (270) 886-1274 | |
| (270) 886-8307 |
| Full Name | Matthew Scott Robinson |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 22 Years |
| Location | 1722 High St, Hopkinsville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659406932 | NPI | - | NPPES |
| 000000514491 | Other | KY | ANTHEM |
| 7100018420 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 40522 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jennie Stuart Medical Center | Hopkinsville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jennie Stuart Medical Center Inc | 4183607252 | 99 |
News Archive
A tiny variation in a gene known as CHI3L1 increases susceptibility to asthma, bronchial hyperresponsiveness and decline in lung function, researchers report early online in the New England Journal of Medicine.
PreXion, Inc., the leader in high quality 3D Cone Beam Imaging systems for dentistry, today announced that it has launched and started shipping new PreXion3D Volumetric Imaging Software for its 3D Cone Beam Computed Tomography system for dentistry. This new product incorporates a range of advanced features including tools for implant planning and placement and an enhanced version of its PrexViewer software.
Endo Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved FORTESTA Gel for the treatment of low testosterone, or 'Low T,' also known as hypogonadism. Symptoms associated with Low T include erectile dysfunction and decreased sexual desire, fatigue and loss of energy, mood depression, regression of secondary sexual characteristics and osteoporosis.
Within six months of the U.S. Food and Drug Administration's move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.
› Verified 8 days ago
| Entity Name | Jennie Stuart Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235139312 PECOS PAC ID: 4183607252 Enrollment ID: O20040609001506 |
News Archive
A tiny variation in a gene known as CHI3L1 increases susceptibility to asthma, bronchial hyperresponsiveness and decline in lung function, researchers report early online in the New England Journal of Medicine.
PreXion, Inc., the leader in high quality 3D Cone Beam Imaging systems for dentistry, today announced that it has launched and started shipping new PreXion3D Volumetric Imaging Software for its 3D Cone Beam Computed Tomography system for dentistry. This new product incorporates a range of advanced features including tools for implant planning and placement and an enhanced version of its PrexViewer software.
Endo Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved FORTESTA Gel for the treatment of low testosterone, or 'Low T,' also known as hypogonadism. Symptoms associated with Low T include erectile dysfunction and decreased sexual desire, fatigue and loss of energy, mood depression, regression of secondary sexual characteristics and osteoporosis.
Within six months of the U.S. Food and Drug Administration's move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.
› Verified 8 days ago
| Entity Name | Fairview Physicians Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821385329 PECOS PAC ID: 7012187925 Enrollment ID: O20110901000656 |
News Archive
A tiny variation in a gene known as CHI3L1 increases susceptibility to asthma, bronchial hyperresponsiveness and decline in lung function, researchers report early online in the New England Journal of Medicine.
PreXion, Inc., the leader in high quality 3D Cone Beam Imaging systems for dentistry, today announced that it has launched and started shipping new PreXion3D Volumetric Imaging Software for its 3D Cone Beam Computed Tomography system for dentistry. This new product incorporates a range of advanced features including tools for implant planning and placement and an enhanced version of its PrexViewer software.
Endo Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved FORTESTA Gel for the treatment of low testosterone, or 'Low T,' also known as hypogonadism. Symptoms associated with Low T include erectile dysfunction and decreased sexual desire, fatigue and loss of energy, mood depression, regression of secondary sexual characteristics and osteoporosis.
Within six months of the U.S. Food and Drug Administration's move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Scott Robinson, MD 1722 High St, Hopkinsville, KY 42240-1936 Ph: (270) 886-1274 | Matthew Scott Robinson, MD 1722 High St, Hopkinsville, KY 42240-1936 Ph: (270) 886-1274 |
News Archive
A tiny variation in a gene known as CHI3L1 increases susceptibility to asthma, bronchial hyperresponsiveness and decline in lung function, researchers report early online in the New England Journal of Medicine.
PreXion, Inc., the leader in high quality 3D Cone Beam Imaging systems for dentistry, today announced that it has launched and started shipping new PreXion3D Volumetric Imaging Software for its 3D Cone Beam Computed Tomography system for dentistry. This new product incorporates a range of advanced features including tools for implant planning and placement and an enhanced version of its PrexViewer software.
Endo Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved FORTESTA Gel for the treatment of low testosterone, or 'Low T,' also known as hypogonadism. Symptoms associated with Low T include erectile dysfunction and decreased sexual desire, fatigue and loss of energy, mood depression, regression of secondary sexual characteristics and osteoporosis.
Within six months of the U.S. Food and Drug Administration's move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.
› Verified 8 days ago
Dr. George R Valentini, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1724 Kenton St, Suite 1c, Hopkinsville, KY 42240 Phone: 270-885-1140 Fax: 270-885-1183 | |
Jack Thomas Giannini, PSC Surgery Medicare: Not Enrolled in Medicare Practice Location: 220 W 18th St, Hopkinsville, KY 42240 Phone: 270-886-7512 Fax: 270-886-0174 | |
Francis M Vanmeter, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1722 High St, Hopkinsville, KY 42240 Phone: 270-886-1274 Fax: 270-886-8307 | |
Dr. David Wanjohi Kabithe, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1722 High St, Hopkinsville, KY 42240 Phone: 270-885-8505 | |
Gerame Tate Wells, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1724 Kenton St, Suite 2b, Hopkinsville, KY 42240 Phone: 270-632-4555 Fax: 270-632-4556 |